Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Viral Load Still at 64 After Months of Meds
Jun 29, 2014

I want to thank Dr. Holodniy & others here who answer questions, I appreciate it so much. I hope you can help me.

After 6 months of being on Complera, my recent test results are HIV 1 RNA, QN PCR 64 and HIV 1 RNA, QN PCR 1.81

This means my viral load is 64 copies/ML: My question is: What technically is considered 'undetectable'? Zero? And why does it show 64 after so many months of this drug?

Thank you!

Response from Dr. Holodniy

You don't indicate what your viral load was before starting treatment or whether a resistance test was performed to determine if your viral strain had any resistance to HIV drugs. In general, most people would have an undetectable viral load (< 40 or < 20 copies/mL) 6 months after starting HIV treatment, but is some people it may take a few more weeks.



Previous
Treatment
Next
Hep A B C lab

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement